ORGAN I NR by Par Pharmaceutical
Medically reviewed on October 31, 2017
Dosage form: tablet
Ingredients: GUAIFENESIN 200mg
Labeler: Par Pharmaceutical
NDC Code: 0603-4890
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
(in each immediate-release tablet)
Guaifenesin USP, 200 mg
Helps loosen phlegm(mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Ask a doctor before use if you have
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- cough accompanied by too much phlegm(mucus)
stop use and ask a doctor if cough lasts more than 7 days, comes back, or is accompanied by fever, rash or persistent headache. This could be signs of a serious illness.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
- do not take more than 6 doses in any 24-hour period
- this product is not intended for use in children under 12 years of age
adults and children 12 years and over 1 to 2 tablets every 4 hours Children under 12 years Do not use
- store at 15-30 °C (59-86 °F)
- you may report serious side effects to: 130 Vintage Drive, Huntsville, AL 35811
Colloidal silicon dioxide, FD&C red #40(Al-lake), magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, stearic acid
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
Made in the USA
for Qualitest Pharmaceuticals,
Huntsville, AL 35811
Rev 4/15 R0
|ORGAN I NR
|Labeler - Par Pharmaceutical (011103059)|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.